Skip to main content
OpenTrials
Completed

NCT Number: NCT04323787

Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry

Researchers are creating a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronavirus COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Loading trial locations.

About this study

Investigators aim is to create a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals.

Such a set of standards would increase the quality of single and multi-center studies, national registries as well as aggregation syntheses such as meta-analyses. It will also be of utmost importance in tiring times of public health emergencies and will help understand practice variability and outcomes during COVID-19 pandemic.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • COVID-19 PCR positive (within 7 days)
  • COVID-19 PCR pending
  • COVID-19 high clinical suspicion

Exclusion criteria

  • Patient without Prior Research Authorization (applicable to Mayo Clinic sites)
  • Non COVID-19 related admissions
  • Repeated Admission to ICUs/Hospital

Treatment and study plan

Observational

Other

No Intervention

Other names: No Intervention

Primary outcomes

  1. ICU and hospital mortality of COVID-19 patients

    Time frame: 7 days

    Primary outcome will be to measure ICU and hospital mortality up to 7 days of COVID-19 patients

Secondary outcomes

  1. 30 days mortality

    Time frame: 30 days

    Secondary outcome will be to measure 30 days mortality from Hospital discharge

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Collaborators

  • Boston University
  • Society of Critical Care Medicine

Registry information

Official study title

Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry and Validation of C2D2 (Critical Care Data Dictionary)

Acronym: COVID-19

Important dates

Study start
2020
Primary completion
2025
Study completion
2025
First posted
Mar 27, 2020
Registry last updated
Apr 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.